ARVN
Price
$24.67
Change
+$0.19 (+0.78%)
Updated
Oct 4, 02:41 PM (EDT)
32 days until earnings call
PMVP
Price
$1.48
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
34 days until earnings call
Ad is loading...

ARVN vs PMVP

Header iconARVN vs PMVP Comparison
Open Charts ARVN vs PMVPBanner chart's image
Arvinas
Price$24.67
Change+$0.19 (+0.78%)
Volume$211
CapitalizationN/A
PMV Pharmaceuticals
Price$1.48
Change-$0.00 (-0.00%)
Volume$127.73K
CapitalizationN/A
View a ticker or compare two or three
ARVN vs PMVP Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ARVN vs. PMVP commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a StrongBuy and PMVP is a Hold.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (ARVN: $24.48 vs. PMVP: $1.48)
Brand notoriety: ARVN and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 94% vs. PMVP: 60%
Market capitalization -- ARVN: $1.69B vs. PMVP: $76.76M
ARVN [@Biotechnology] is valued at $1.69B. PMVP’s [@Biotechnology] market capitalization is $76.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, ARVN is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 3 bearish.
  • PMVP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than PMVP.

Price Growth

ARVN (@Biotechnology) experienced а +0.49% price change this week, while PMVP (@Biotechnology) price change was -0.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 05, 2024.

PMVP is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($1.69B) has a higher market cap than PMVP($76.8M). ARVN YTD gains are higher at: -40.525 vs. PMVP (-52.258). PMVP has higher annual earnings (EBITDA): -75.47M vs. ARVN (-364.2M). ARVN has more cash in the bank: 1.23B vs. PMVP (213M). ARVN has less debt than PMVP: ARVN (2.1M) vs PMVP (13M). ARVN has higher revenues than PMVP: ARVN (93.3M) vs PMVP (0).
ARVNPMVPARVN / PMVP
Capitalization1.69B76.8M2,202%
EBITDA-364.2M-75.47M483%
Gain YTD-40.525-52.25878%
P/E RatioN/AN/A-
Revenue93.3M0-
Total Cash1.23B213M577%
Total Debt2.1M13M16%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNPMVP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVLVX14.15N/A
N/A
Avantis U.S. Large Cap Value Inst
JVMAX28.90-0.10
-0.34%
JHancock Disciplined Value Mid Cap A
FKICX12.42-0.05
-0.40%
Fidelity Small Cap Stock K6
FSMLX26.16-0.15
-0.57%
Franklin Small Cap Growth R6
TEMGX10.12-0.13
-1.27%
Templeton Global Smaller Comp A

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ABCL. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-0.89%
ABCL - ARVN
55%
Loosely correlated
N/A
CRBU - ARVN
49%
Loosely correlated
+0.56%
IPSC - ARVN
47%
Loosely correlated
-6.21%
KYMR - ARVN
46%
Loosely correlated
-3.53%
SNDX - ARVN
46%
Loosely correlated
-3.86%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with MDGL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-0.67%
MDGL - PMVP
44%
Loosely correlated
-1.23%
ARVN - PMVP
34%
Loosely correlated
-0.89%
CARM - PMVP
33%
Loosely correlated
-3.72%
ORMP - PMVP
33%
Loosely correlated
+0.84%
RPTX - PMVP
33%
Loosely correlated
+0.29%
More